NEW YORK (GenomeWeb News) – Qiagen today reported third-quarter revenue growth of 31 percent, with its molecular diagnostics products having a particularly strong quarter with 38 percent growth year over year.
 
The firm had total revenues of $230.8 million for the three-month period ended Sept. 30, compared to revenues of $176.6 million for the third quarter of 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more